| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
gap junction protein alpha 1 | 0.393 | 0.885 | 0.16 |
|
phenotype | 0.700 | None | 0.969 | 32 | 1 | 2006 | 2019 | ||||||||
|
potassium voltage-gated channel subfamily H member 2 | 0.522 | 0.731 | 1.00 |
|
phenotype | 0.500 | None | 1.000 | 78 | 29 | 1995 | 2020 | ||||||||
|
opioid receptor kappa 1 | 0.555 | 0.615 | 4.1E-05 |
|
phenotype | 0.500 | None | 1.000 | 2 | 0 | 2004 | 2006 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
phenotype | 0.380 | None | 1.000 | 9 | 0 | 2004 | 2019 | ||||||||
|
calcium voltage-gated channel subunit alpha1 C | 0.510 | 0.846 | 1.00 |
|
phenotype | 0.380 | None | 1.000 | 9 | 1 | 2004 | 2019 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 2 | 0.572 | 0.731 | 0.31 |
|
phenotype | 0.370 | None | 1.000 | 9 | 3 | 2004 | 2017 | ||||||||
|
potassium voltage-gated channel subfamily E regulatory subunit 2 | 0.628 | 0.423 | 1.0E-04 |
|
phenotype | 0.360 | None | 1.000 | 7 | 2 | 2001 | 2016 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
phenotype | 0.330 | None | 1.000 | 5 | 0 | 1989 | 2018 | ||||||||
|
endothelin 1 | 0.380 | 0.846 | 0.46 |
|
phenotype | 0.330 | None | 0.750 | 4 | 0 | 2002 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 4 | 0.610 | 0.615 | 2.5E-02 |
|
phenotype | 0.330 | None | 1.000 | 4 | 0 | 1998 | 2007 | ||||||||
|
potassium voltage-gated channel subfamily D member 3 | 0.619 | 0.615 | 0.99 |
|
phenotype | 0.320 | limited | 1.000 | 3 | 0 | 2000 | 2012 | ||||||||
|
protein phosphatase 1 regulatory inhibitor subunit 1A | 0.559 | 0.692 | 2.2E-02 |
|
phenotype | 0.320 | None | 1.000 | 3 | 1 | 2010 | 2015 | ||||||||
|
blood vessel epicardial substance | 0.722 | 0.308 | 9.3E-06 |
|
phenotype | 0.320 | limited | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
catenin alpha 3 | 0.612 | 0.692 | 1.0E-12 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
potassium voltage-gated channel subfamily E regulatory subunit 1 | 0.588 | 0.615 | 3.4E-03 |
|
phenotype | 0.300 | None | 1.000 | 13 | 2 | 1997 | 2019 | ||||||||
|
thyrotropin releasing hormone | 0.519 | 0.846 | 8.9E-04 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 1982 | 1982 | ||||||||
|
shugoshin 1 | 0.674 | 0.346 | 2.6E-12 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
cyclin and CBS domain divalent metal cation transport mediator 2 | 0.641 | 0.346 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
opioid related nociceptin receptor 1 | 0.628 | 0.462 | 0.48 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
calcium voltage-gated channel auxiliary subunit alpha2delta 1 | 0.641 | 0.500 | 1.00 |
|
phenotype | 0.300 | limited | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
solute carrier family 22 member 5 | 0.608 | 0.731 | 5.3E-16 |
|
phenotype | 0.300 | limited | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
arginine vasopressin | 0.437 | 0.846 | 7.4E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 1982 | 1982 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 8 | 0.619 | 0.538 | 0.38 |
|
phenotype | 0.300 | moderate | 1.000 | 1 | 1 | 2011 | 2011 |